Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Children
Clinical trial NCT04816643 · COMPLETED
Trial details
- NCT number
- NCT04816643
- Sponsor
- BioNTech SE
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-24
- Primary completion
- 2023-10-04
- Enrollment
- 11837
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.